Literature DB >> 17982038

Memory CD8+ T cells require CD28 costimulation.

Annie B Borowski1, Alina C Boesteanu, Yvonne M Mueller, Caterina Carafides, David J Topham, John D Altman, Stephen R Jennings, Peter D Katsikis.   

Abstract

CD8(+) T cells are a critical component of the adaptive immune response against infections and tumors. A current paradigm in immunology is that naive CD8(+) T cells require CD28 costimulation, whereas memory CD8(+) T cells do not. We show here, however, that during viral infections of mice, costimulation is required in vivo for the reactivation of memory CD8(+) T cells. In the absence of CD28 costimulation, secondary CD8(+) T cell responses are greatly reduced and this impairs viral clearance. The failure of CD8(+) T cells to expand in the absence of CD28 costimulation is CD4(+) T cell help independent and is accompanied by a failure to down-regulate Bcl-2 and by cell cycle arrest. This requirement for CD28 costimulation was shown in both influenza A and HSV infections. Thus, contrary to current dogma, memory CD8(+) T cells require CD28 costimulation to generate maximal secondary responses against pathogens. Importantly, this CD28 requirement was shown in the context of real infections were multiple other cytokines and costimulators may be up-regulated. Our findings have important implications for pathogens, such as HIV and measles virus, and tumors that evade the immune response by failing to provide CD28 costimulation. These findings also raise questions about the efficacy of CD8(+) T cell-based vaccines against such pathogens and tumors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17982038     DOI: 10.4049/jimmunol.179.10.6494

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  71 in total

Review 1.  Plasticity in programming of effector and memory CD8 T-cell formation.

Authors:  Ramon Arens; Stephen P Schoenberger
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Rapid Evolution of the CD8+ TCR Repertoire in Neonatal Mice.

Authors:  Alison J Carey; Donald T Gracias; Jillian L Thayer; Alina C Boesteanu; Ogan K Kumova; Yvonne M Mueller; Jennifer L Hope; Joseph A Fraietta; David B H van Zessen; Peter D Katsikis
Journal:  J Immunol       Date:  2016-02-12       Impact factor: 5.422

3.  Manipulating Memory CD8 T Cell Numbers by Timed Enhancement of IL-2 Signals.

Authors:  Marie T Kim; Samarchith P Kurup; Gabriel R Starbeck-Miller; John T Harty
Journal:  J Immunol       Date:  2016-07-20       Impact factor: 5.422

4.  Biopolymer encapsulated live influenza virus as a universal CD8+ T cell vaccine against influenza virus.

Authors:  Alina C Boesteanu; Nadarajan S Babu; Margaret Wheatley; Elisabeth S Papazoglou; Peter D Katsikis
Journal:  Vaccine       Date:  2010-10-27       Impact factor: 3.641

5.  Differential requirements for CD80/86-CD28 costimulation in primary and memory CD4 T cell responses to vaccinia virus.

Authors:  Shinichiro Fuse; Ching-Yi Tsai; Leah M Rommereim; Weijun Zhang; Edward J Usherwood
Journal:  Cell Immunol       Date:  2010-10-30       Impact factor: 4.868

Review 6.  Heterogeneous memory T cells in antiviral immunity and immunopathology.

Authors:  David Verhoeven; John R Teijaro; Donna L Farber
Journal:  Viral Immunol       Date:  2008-06       Impact factor: 2.257

7.  CD28 co-signaling in the adaptive immune response.

Authors:  Pavel Riha; Christopher E Rudd
Journal:  Self Nonself       Date:  2010-07-12

8.  Induction of death receptor CD95 and co-stimulatory molecules CD80 and CD86 by meningococcal capsular polysaccharide-loaded vaccine nanoparticles.

Authors:  Ruhi V Ubale; Rikhav P Gala; Susu M Zughaier; Martin J D'Souza
Journal:  AAPS J       Date:  2014-07-01       Impact factor: 4.009

Review 9.  Biochemical signaling pathways for memory T cell recall.

Authors:  Donna L Farber
Journal:  Semin Immunol       Date:  2009-04       Impact factor: 11.130

10.  CD28-B7 interaction modulates short- and long-lived plasma cell function.

Authors:  Modesta N Njau; Jin Hyang Kim; Craig P Chappell; Rajesh Ravindran; Leela Thomas; Bali Pulendran; Joshy Jacob
Journal:  J Immunol       Date:  2012-08-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.